Medical management of advanced gastric cancer

被引：41

作者：

Hill, ME ^{[1
]}

Cunningham, D ^{[1
]}

机构：

[1] Royal Marsden NHS Trust, GI Unit, Sutton SM2 5PT, Surrey, England

来源：

CANCER TREATMENT REVIEWS | 1998年 / 24卷 / 02期

关键词：

D O I：

10.1016/S0305-7372(98)90077-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：113 / 118

页数：6

共 59 条

[1]

AJANI JA, 1997, P AN M AM SOC CLIN, V16, pA263

[2] GASTRIC-CANCER - A 25-YEAR REVIEW [J].

ALLUM, WH ;

POWELL, DJ ;

MCCONKEY, CC ;

FIELDING, JWL .

BRITISH JOURNAL OF SURGERY, 1989, 76 (06) :535-540

[3]

[Anonymous], J NATL CANC I

[4]

BAKER LH, 1976, CANCER-AM CANCER SOC, V38, P1, DOI 10.1002/1097-0142(197607)38:1<1::AID-CNCR2820380102>3.0.CO

[5]

2-S

[6] Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase [J].

Baker, SD ;

Khor, SP ;

Adjei, AA ;

Doucette, M ;

Spector, T ;

Donehower, RC ;

Grochow, LB ;

Sartorius, SE ;

Noe, DA ;

Hohneker, JA ;

Rowinsky, EK .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (12) :3085-3096

[7]

BAMIAS A, 1996, CANCER, V76, P1978

[8]

BRUCKNER HW, 1982, CANCER TREAT REP, V66, P1713

[9] Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: A report from the Italian group for the study of digestive tract cancer [J].

Cascinu, S ;

Labianca, R ;

Alessandroni, P ;

Marcellini, M ;

Silva, RR ;

Pancera, G ;

Testa, E ;

Martignoni, G ;

Barni, S ;

Frontini, L ;

Zaniboni, A ;

Luporini, G ;

Cellerino, R ;

Catalano, G .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (11) :3313-3319

[10]

CAZAP E, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P91

← 1 2 3 4 5 6 →